Osteosarcoma Following Growth Hormone Therapy in Recurrent Acute Lymphoblastic Leukemia and Rapadilino Syndrome

Claudio SandovalDepartment of Pediatrics, New York Medical College and Maria Fareri Children's Hospital, Valhalla, New York, USACorrespondence[email protected]

Julie DunbarDepartment of Pediatrics, New York Medical College and Maria Fareri Children's Hospital, Valhalla, New York, USA

Mehmet OzkaynakDepartment of Pediatrics, New York Medical College and Maria Fareri Children's Hospital, Valhalla, New York, USA

Somasundaram JayaboseDepartment of Pediatrics, New York Medical College and Maria Fareri Children's Hospital, Valhalla, New York, USA

REFERENCES

Borgmann A, Zinn C, Hartmann R, et al. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukemia in childhood. Eur J Cancer. 2008;44:257–268.
PubMed Web of Science ®Google Scholar
Mody R, Li S, Dover DC, Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111:5515–5523.
PubMed Web of Science ®Google Scholar
Hijiya N, Hudson MM, Lensing S, Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA. 2007;297:1207–1215.
PubMed Web of Science ®Google Scholar
Rizzo JD, Curtis RE, Socie G, Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009;113:1175–1183.
PubMed Web of Science ®Google Scholar
Sklar CA, Mertens AC, Mitby P, Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2002;87:3136–3141.
PubMed Web of Science ®Google Scholar
Ergun-Longmire B, Mertens AC, Mitby P, Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab. 2006;91:3494–3498.
PubMed Web of Science ®Google Scholar
Leung W, Rose SR, Zhou Y, Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2002;20:2959–2964.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Osteosarcoma Following Growth Hormone Therapy in Recurrent Acute Lymphoblastic Leukemia and Rapadilino Syndrome

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Osteosarcoma Following Growth Hormone Therapy in Recurrent Acute Lymphoblastic Leukemia and Rapadilino Syndrome

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date